Books on the topic 'Angiotensin converting enzyme Cancer'

A, MacGregor G., and Sever Peter S, eds. Current advances in ACE inhibition 2: Proceedings of an Internationalsymposium, Queen Elizabeth II Conference Centre, London, UK 17-21 February 1991. Edinburgh: Churchill Livingstone, 1991.

Townend, Jonathan Nicholas. Studies on angiotensin converting enzyme inhibitors in heart failure. Birmingham: University of Birmingham, 1994.

H, Opie Lionel. Angiotensin-converting enzyme inhibitors: Scientific basis for clinical use. New York: Wiley-Liss, 1992.

H, Opie Lionel. Angiotensin-converting enzyme inhibitors: Scientific basis for clinical use. New York: Wiley-Liss, 1992.

George, Strube, ed. ACE inhibitors in hypertension: A guide for general practitioners. Dordrecht: Kluwer Academic Publishers, 1992.

O'Donnell, Mark John. The kidney in diabetes mellitus: Urinary transfer in excretion, hypertension, the Renin-Angiotensin-Aldosteronesystem, and the role of angiotensin converting enzyme inhibitors in therapy. Birmingham: University of Birmingham, 1992.

J, Whalley Lawrence, ed. ACE inhibitors: Central actions. New York: Raven Press, 1994.

The ACE inhibitor/myocardial infarction trials: From clinical trials to clinical practice. Beckenham: Publishing Initiatives Books, 1995.

Morlin, A. J. G. The preparation of some chiral 2-hydroxycarboxylic acids and their use in the synthesisof potential angiotensin converting enzyme inhibitors. Norwich: University of East Anglia, 1993.

Bosch, Sophie J. Effectiveness of Ace inhibitors and ARBs in heart disease treatment. Hauppauge, N.Y: Nova Science Publishers, 2011.

Parker, James N., and Philip M. Parker. Lisinopril: A medical dictionary, bibliography, and annotated research guide to Internet references. San Diego, CA: ICON Health Publications, 2004.

Arfi, Robert A. Systolic blood pressure: Influences, associations, and management. Hauppauge, N.Y: Nova Science Publishers, 2012.

N, DeBrue Anne, ed. Angiotensin converting enzyme inhibitors. New York: Nova Biomedical Books, 2009.

K, Ferguson Roger, and Vlasses Peter, eds. Angiotensin-converting enzyme inhibitors. Mount Kisco, N.Y: Futura Pub. Co., 1987.

Angiotensin converting enzyme inhibitors. New York: Nova Biomedical Books, 2009.

B, Kostis John, and DeFelice Eugene A, eds. Angiotensin converting enzyme inhibitors. New York: Liss, 1987.

H, Opie Lionel. Angiotensin Converting Enzyme Inhibitors. University of Cape Town Press,South Africa, 1998.

L, Clement Denis, ed. Angiotensin converting enzyme inhibitors: Past, present and beyond. London: Royal Society of Medicine Services, 1989.

D, Giles Thomas, ed. Angiotensin-converting enzyme (ACE): Clinical and experimental insights. Fort Lee, N.J: Health Care Communications, Inc., 2001.

Giles, Thomas D. Angiotensin-Converting Enzyme (Ace): Clinical and Experimental Insights. Health Care Communications, 2001.

Graham, MacGregor, Sever Peter S, International Symposium on ACE Inhibition (1st : 1989 : London, England), and International Symposium on ACE Inhibition (2nd : 1991 : London, England), eds. Current advances in ACE inhibition. Edinburgh: Churchill Livingstone, 1989.

(Editor), Graham A. MacGregor, and Peter S. Sever (Editor), eds. Current Advances Ace Inhibition 2 (Current Advances in ACE Inhibition). Churchill Livingstone, 1997.

Angiotensin-Converting Enzyme Inhibitors: Scientific Basis for Clinical Use, 2E. Wiley-Liss, 1994.

Rosenthal, J. Focus on Angiotensin-Converting Enzyme Inhibition (Clinical Physiology and Biochemistry,). S. Karger AG (Switzerland), 1990.

Cardinale, Daniela, and Carlo Maria Cipolla. Anthracycline-related cardiotoxicity: epidemiology, surveillance, prophylaxis, management, and prognosis. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198784906.003.0290.

David, Caldwell, MacGregor Graham, and Sever Peter S, eds. Current advances in ACE inhibition 2: Proceedings of an international symposium, Queen Elizabeth II Conference Centre, London, UK, 17-21 February, 1991. Edinburgh: Churchill Livingstone, 1991.

1932-, Sonnenblick Edmund H., Laragh John H. 1924-, and Lesch Michael, eds. New frontiers in cardiovascular therapy: Focus on angiotensin converting enzyme inhibition. Princeton: Excerpta Medica, 1989.

Cesare, Dal Palù, Unger Thomas, and European Society of Hypertension, eds. ACE Inhibition, Hypertension and Related Diseases. Chichester, Sussex: Media Medica, 1993.

Angiotensin. Berlin: Springer, 2004.

1957-, D'Orléans-Juste P., and Plante G. E, eds. ACE inhibitors. Basel: Birkhäuser Verlag, 2001.

ACE Inhibitors: Current Use and Future Prospects. Informa Healthcare, 1994.

1941-, Schachter Michael, ed. ACE inhibitors, current use and future prospects. London: Martin Dunitz, 1995.

Spratt, Thomas E. Mechanistic studies on Zn(II)- and Co(II)- carboxypeptidase A and angiotensin converting enzyme. 1985.

Timmermans, P. B. M. W. M. and Wexler Ruth R, eds. Medicinal chemistry of the renin-angiotensin system. Lausanne: Elsevier, 1994.

Ung, Emily. Evaluation of angiotensin-converting enzyme inhibitor dosage in patients with congestive heart failure at the Toronto Hospital. 1995.

The reduction in alcohol intake produced by angiotensin converting enzyme inhibitors: Mechanism of action and clinical ramifications. Ottawa: National Library of Canada = Bibliothèque nationale du Canada, 1993.

(Editor), Thomas Unger, and Bernward A. Schölkens (Editor), eds. Angiotensin - Vol. I (Handbook of Experimental Pharmacology). Springer, 2004.

Longman, Susan Dawn. Cardiovascular studies with angiotensin converting enzyme inhibitors in the rat: Effects of arterial blood pressure and plasma and tissue angiotensin converting enzyme (ACE) activity of acute and chronic administration of ACE inhibitors in sodium deficient normotensive (NT) rats. Bradford, 1986.

F, Cleland John G., ed. The Clinician's guide to ACE inhibition. Edinburgh: Churchill Livingstone, 1993.

Cardiovascular and sympathoadrenal effects of "new pressor protein": Role of angiotensin converting enzyme, neutral endopeptidase and substance P. Ottawa: National Library of Canada, 2003.

T, Dollery Colin, Sherwood Louis M, and Medical Advisory Council (Merck, Sharp & Dohme International), eds. Cardiac and renal failure: An expanding role for ACE inhibitors. Philadelphia: Hanley & Belfus, 1989.

(Editor), Naranjan S. Dhalla, Peter Zahradka (Editor), Ian M.C. Dixon (Editor), and Robert E. Beamish (Editor), eds. Angiotensin II Receptor Blockade: (Progress in Experimental Cardiology). Springer, 1998.

S, Dhalla Naranjan, and Manitoba Cardovascular Forum on Angiotensin Receptor Blockade (1996 : Winnipeg, Man.), eds. Angiotensin II receptor blockade: Physiological and clinical implications. Boston: Kluwer Academic Publishers, 1998.

(Editor), Thomas Unger, and Bernward A. Schölkens (Editor), eds. Angiotensin - Vol. II (Handbook of Experimental Pharmacology) (Handbook of Experimental Pharmacology). Springer Verlag, 2004.

Garrib, Alam. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene in patients who misuse alcohol or in patientswith renal artery stenosis. 1995.

C, Fasciolo J., ed. Enalapril. London, England: Science Press, 1991.

Fasciolo, Juan Carlos. Enalapril (The Landmark Papers). Science Press, 1991.

K. P. Anula P. Kariyawasam. "New pressor protein (NPP)": Functional relationship to coagulation factor FXII and potentiation of its cardiovascular effects by angiotensin I converting enzyme inhibitor captopril. 2001.

Stebelsky, Lesia Anne Eva. Patterns of prescribing practices in hypercholesterolemia, heart failure and post-myorcardial infarction: examining the use of angiotensin converting enzyme inhibitors and cholesterol lowering agents. 1998.

Walsh, David. Attenuation of ventricular remodelling post myocardial infarction: A systematic review of the evidence of treatment with angiotensin converting enzyme inhibitors, nitrates and beta blockers. 1999.